HBV transmission from an occult carrier with five mutations in the major hydrophilic region of HBsAg to an immunosuppressed plasma recipient

Journal of Clinical Virology

Volumn 58, Issue 1, 2013, Pages 315-317

  Coppola, Nicola ^a   Loquercio, Giovanna ^b   Tonziello, Gilda ^a   Azzaro, Rosa ^b   Pisaturo, Mariantonietta ^a   Di Costanzo, Gaetano ^b   Starace, Mario ^a   Pasquale, Giuseppe ^a   Cacciapuoti, Carmela ^b   Petruzziello, Arnolfo ^b  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

HBsAg mutants; HBV infection; Occult HBV infection; Transfusion

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ADULT; AMINO ACID SUBSTITUTION; ANTIBODY TITER; ARTICLE; BLOOD DONOR; DISEASE TRANSMISSION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MALE; PRIORITY JOURNAL;

EID: 84881523877     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2013.06.020     Document Type: Article

References (13)

1. Raimondo G., Allain J.P., Brunetto M.R., Buendia M.A., Chen D.S., Colombo M., et al. Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol 2008, 49:652-657.
2. Sagnelli E., Imparato M., Coppola N., Pisapia R., Sagnelli C., et al. Diagnosis and clinical impact of occult hepatitis B infection in patients with biopsy proven hepatitis C: a multicenter study. J Med Virol 2008, 80:1547-1553.
3. Coppola N., Tonziello G., Pisaturo M., Messina V., Guastafierro S., Fiore M., et al. Reactivation of overt and occult hepatitis B infection in various immunosuppressive settings. J Med Virol 2011, 83:1909-1916.
4. Carman W.F., Zanetti A.R., Karayiannis P., Waters J., Manzillo G., Tanzi E., et al. Vaccine-induced escape mutant of hepatitis B virus. Lancet 1990, 336:325-329.
5. Chotiyaputta W., Lok A.S. Hepatitis B virus variants. Nat Rev Gastroenterol Hepatol 2009, 6:453-462.
6. Coppola N., Potenza N., Pisaturo M., Mosca N., Tonziello G., Signoriello G., et al. Liver microRNA hsa-miR-125a-5p in HBV chronic infection: correlation with HBV replication and disease progression. PlosOne 2013, 10. 1371/journal.pone.0065336.
7. Candotti D., Allain J.P. Transfusion-transmitted hepatitis B virus infection. J Hepatol 2009, 51:798-880.
8. El Chaar M., Candotti D., Crowther R.A., Allain J.P. Impact of hepatitis B virus surface protein mutations on the diagnosis of occult hepatitis B virus infection. Hepatology 2010, 52:1600-1610.
9. Candotti D., Grabarczyk P., Ghiazza P., Roig R., Casamitjana N., Iudicone P., et al. Characterization of occult hepatitis B virus from blood donors carrying genotype A2 or genotype D strains. J Hepatol 2008, 49:537-547.
10. Ireland J.H., O'Donnell B., Basuni A.A., Kean J.D., Wallace L.A., Lau G.K., et al. Reactivity of 13 in vitro expressed hepatitis B surface antigen variants in 7 commercial diagnostic assays. Hepatology 2000, 31:1176-1182.
11. Huang C.H., Yuan Q., Chen P.J., Zhang Y.L., Chen C.R., Zheng Q.B., et al. Influence of mutations in hepatitis B virus surface protein on viral antigenicity and phenotype in occult HBV strains from blood donors. J Hepatol 2012, 57:720-729.
12. Verheyen J., Neumann-Fraune M., Berg T., Kaiser R., Obermeier M. The detection of HBsAg mutants expressed in vitro using two different quantitative HBsAg assays. J Clin Virol 2012, 54:279-281.
13. Svicher V., Cento V., Bernassola M., Neumann-Fraune M., Van Hemert F., Chen M., et al. Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detection. Antiviral Res 2012, 93:86-93.